Manufacturing
November 1, 2026 · Jimmy Cho
Pharma Research Nearly Doubles Cosmetics, Signs for US Plant
Kyobo estimates Pharma Research's Q3 cosmetics sales up 93.8%. It signed for a California plant, and the estimated operating margin falls to 34.0%.
November 1, 2026 · Jimmy Cho
Mary Kay’s New K-Beauty Line Proves Country of Origin Is Now a Free License
Mary Kay launched three Korea-made skincare products in 40 markets without naming the manufacturer or prices. What that means for Korean suppliers.
October 20, 2026 · Jimmy Cho
Kolmar Korea Says Fakes Are K-Beauty's Biggest Problem. It Owns No Trademark to Fight Them.
Kolmar Korea named overseas counterfeits as K-beauty's biggest problem. The manufacturer holds no trademark, and a US sunscreen is a drug, not a cosmetic.
October 15, 2026 · Jimmy Cho
Foreign Giants Are Quietly Colonizing the Korean Cosmetics Supply Chain
At the end of June 2026, four separate foreign institutions each held more than 5% of Cosmax: Fidelity International at 5.33%, Singapore’s GIC at 6.33%, Norges Bank at 6.08% and the Government of Singapore at 5.40%. Across Korea’s 500 largest listed companies, cosmetics went from two such holdings to nine in twelve months, the sharpest rise of any sector. The money is not landing where the brand headlines are. It is landing on the factory.
October 4, 2026 · Jimmy Cho
Mexico Taxed K-Beauty 36%. Korea Signed a Paperwork Mirage.
Mexico’s 2026 import tariff overhaul raised duty rates on 20 cosmetics lines to 25–36% for non-FTA countries like Korea. Despite President Lee’s September summit yielding 17 cooperation documents and Amorepacific targeting 10x growth, no tariff cuts were secured. Because duties apply at the border, channel shifts cannot bypass them, forcing suppliers, buyers, and ODMs to absorb costs or relocate production.
October 2, 2026 · Jimmy Cho
Why US Investors Are Buying the Wrong K-Beauty Stocks
Despite South Korea's record $1.51B cosmetics exports in September 2026, stock prices diverged sharply based on revenue exposure and currency risk rather than total export volume. Overseas-heavy brand owners (e.g., APR, d'Alba) fell over 15–21% due to foreign exchange translation risks, whereas ODM manufacturers (e.g., Cosmax) fell less than half as much by billing domestic clients in won.
September 27, 2026 · Jimmy Cho
C-Beauty Isn't Following K-Beauty's Playbook Anymore
C-beauty is redefining its rivalry with K-beauty by prioritizing ingredient innovation and domestic dominance over brand exports. Chinese cosmetics exports reached $7.8B in 2025, behind Korea’s $11.4B, but firms like Jinbo Bio are licensing Class III medical-grade ingredients to global majors like L'Oréal. Domestically, Chinese brands led H1 2026 with 268.7B yuan ($40B), outgrowing foreign rivals 6.5x.
September 21, 2026 · Jimmy Cho
Macquarie Just Bought the Factory, Not the Brand
Macquarie Asset Management's Korean buyout fund signed a definitive agreement on 18 September 2026 to acquire 70 percent of Hwasung Cosmetics and 100 percent of Nowcos for more than 300 billion won. Its previous Korean purchase, closed in April 2024, was a pharmaceutical contract manufacturer. Neither deal came with a brand, a shelf or a consumer. The K-beauty asset global capital keeps paying for is capacity, and capacity is priced on utilization rather than on desire.
September 17, 2026 · Jimmy Cho
US Customs Wants Real Maker Data: What New CBP Rules Mean for K-Beauty
On 2 September 2026 US Customs and Border Protection published an advance notice of proposed rulemaking under docket USCBP-2026-1058, asking whether importers should identify the manufacturer, shipper, seller, exporter, distributor and packager behind a shipment, each tied to a global business identifier. Comments close on 1 December 2026. The notice never mentions cosmetics. It still reaches furthest into the one export category built on keeping the maker and the brand apart.
September 13, 2026 · Jimmy Cho
The Final Weapon of Global Beauty: Why Korean Manufacturers Are Winning
The success of K-Beauty is driven by South Korea's Original Design Manufacturing (ODM) ecosystem rather than ingredients alone. ODMs streamline R&D, formulation, and production, enabling indie brands to launch products in months while global legacy giants buy into this speed to compete.
September 10, 2026 · Jimmy Cho
Korea's New Regulatory Bloc and the 2028 Mandate Behind It
Korea convened cosmetics regulators from twelve countries in Seoul last week, founded a standing council, took its inaugural chair, secured its permanent secretariat, and booked the second meeting for Korea in 2027. Read in isolation, it is a routine multilateral launch. Read alongside the safety-assessment regime Korea imposes on its own industry from 2028, its purpose becomes considerably more legible — and the implications reach further into the ODM relationship than the announcement suggests.
September 9, 2026 · Jimmy Cho
Kérastase: A Miracle of Innovation Born from Relentless Inquiry
François Dalle transformed Kérastase into a luxury haircare empire. Entering L’Oréal in 1948 with zero industry knowledge, Dalle prioritized field observation (faire la route), realizing salon treatments only disguised damage. In 1964, he launched Kérastase around diagnostic care—a philosophy that now spans targeted product lines, diagnostic tech, and sustainable manufacturing.
August 25, 2026 · Jimmy Cho
Korea's Cosmetics Industry Promotion Act: Who the "Innovative Cosmetics Company" Certification Will Actually Reward
Korea's National Assembly passed the Act on the Fostering and Support of the Cosmetics Industry on 20 August 2026. The only genuinely new instrument in it — certification as an "innovative cosmetics company" — has its qualifying thresholds left entirely to presidential decree. That means the law that decides who benefits will be written over the next twelve months, not last week, and if it is written as an R&D-spending gate it will certify the manufacturers and miss the exporters.
August 19, 2026 · Jimmy Cho
Nilotica Shea and the Korean Ingredient Hub: Why East African Shea Has a Perception Problem, Not a Supply Problem
East African nilotica shea is not held back by capacity or certification. It is held back by the fact that "shea butter" is already a settled category for most formulators and sourcing managers, and what they settled on is the affordable West African version. A Korean refining hub now forming would solve that — while moving the two most valuable steps in the chain from Uganda to Korea.
August 18, 2026 · Jimmy Cho
Unveiling Insights for Online K-Beauty Success: Key K-Beauty Business Trends
The fluorescent lights of an OEM manufacturing plant in Incheon do not sleep. While marketing executives in Manhattan debate the aesthetic appeal of snail mucin, stainless steel reactors in South Korea are churning out custom formulations in forty-eight-hour cycles. The global fascination with Korean beauty is often framed as a triumph of viral aesthetics—a soft-power wave of pastel packaging, glass-skin tutorials, and influencer endorsements. Yet, beneath this polished exterior lies a brutally efficient industrial engine. The real story of K-Beauty is not about gentle botanical extracts. It is about cold, ruthless speed, supply chain supremacy, and an algorithmic response to consumer impulse.
August 17, 2026 · Jimmy Cho
Brenntag's Woojin Trading Deal: Why Global Capital Is Buying the K-Beauty Supply Chain, Not K-Beauty Brands
On 3 August 2026, Germany's Brenntag agreed to acquire Woojin Trading, a Korean beauty ingredients distributor, at an enterprise value KED Global reported at about $35 million. It is the latest in a run of foreign acquisitions targeting the K-beauty supply chain rather than K-beauty brands. The track record of returns over the past three years suggests the buyers have this the right way round: Korean brands bought by global strategics have seen earnings fall, while the packaging and ingredients companies that supply every brand in the category have delivered some of the strongest private equity exits in Korea.
August 8, 2026 · Jimmy Cho
Kolmar Korea's ReefTox Verification: Why Korean ODMs Now Sell Certification, Not Formulas
Kolmar Korea announced on 6 August 2026 that it is the first Korean company to establish a scientific verification system for coral reef sunscreen safety, through French testing organisation ReefTox. The commercially significant part is not the environmental result but the business model: Korean contract manufacturers are increasingly selling clients the ability to make a defensible claim, rather than selling a formulation. This is the same logic behind Kolmar's thirteen-year investment in US FDA over-the-counter certification ahead of the June 2026 bemotrizinol decision.